Ausdal Financial Partners, Inc. - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ausdal Financial Partners, Inc. ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,000
+25.0%
26,000
+62.5%
0.00%0.0%
Q2 2022$4,000
-20.0%
16,0000.0%0.00%0.0%
Q1 2022$5,000
-44.4%
16,0000.0%0.00%0.0%
Q4 2021$9,000
-43.8%
16,0000.0%0.00%
-50.0%
Q3 2021$16,000
-27.3%
16,0000.0%0.00%
-33.3%
Q2 2021$22,000
-18.5%
16,0000.0%0.00%
-40.0%
Q1 2021$27,000
+35.0%
16,0000.0%0.01%
+25.0%
Q4 2020$20,000
-13.0%
16,0000.0%0.00%
-33.3%
Q3 2020$23,000
+76.9%
16,000
+45.5%
0.01%
+50.0%
Q2 2020$13,000
-38.1%
11,000
-26.7%
0.00%
-42.9%
Q1 2020$21,000
-22.2%
15,000
-3.8%
0.01%
-12.5%
Q4 2019$27,000
-37.2%
15,600
-20.5%
0.01%
-46.7%
Q3 2019$43,000
-18.9%
19,6300.0%0.02%
-25.0%
Q2 2019$53,000
-22.1%
19,6300.0%0.02%
-28.6%
Q1 2019$68,000
+51.1%
19,6300.0%0.03%
+27.3%
Q4 2018$45,000
-41.6%
19,630
-1.4%
0.02%0.0%
Q3 2018$77,000
+16.7%
19,900
+1.6%
0.02%
+10.0%
Q2 2018$66,00019,590
+97850.0%
0.02%
Q4 2015$0200.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Perceptive Advisors 12,528,120$38,210,0001.53%
Cormorant Asset Management, LP 850,000$2,593,0000.41%
Palo Alto Investors LP 1,656,644$5,053,0000.24%
Granahan Investment Management 1,745,604$5,324,0000.16%
Spark Investment Management LLC 318,500$980,0000.13%
Opus Point Partners Management, LLC 57,747$176,0000.10%
SHEPHERD KAPLAN KROCHUK, LLC 76,472$233,0000.06%
Joel Isaacson & Co., LLC 70,660$216,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$229,0000.05%
Cornerstone Capital, Inc. 59,200$181,0000.04%
View complete list of ACELRX PHARMACEUTICALS INC shareholders